Profile avatar
minhtrimd.bsky.social
Medical Oncologist at Stanford | Certified Coach | Researcher in emotional intelligence | Always learning, and finding good food. My opinions are my own. #Medsky #Oncosky
22 posts 405 followers 731 following
Regular Contributor
Conversation Starter
Posts 17 Comments 12

No generational judgement—disheartening to see burnout at all. Especially in In a field that clearly still holds joy for those that practice. The landscape is not what it used to be & we’ve trained to be nimble with medical decision—not staffing, prior auth, or EMR burden.

submitted 66 days ago • 0 comments

The FDA has approved trastuzumab deruxtecan (T-DXd) for patients with HR-positive, HER2-low, or HER2-ultralow metastatic breast cancer based on DESTINY-Breast06 trial results. #BreastCancer #Oncology ascopost.com/news/january...

submitted 68 days ago • 0 comments

Thank you for sharing your incredible immigrant story from Vietnam - to selling strawberries on the streets of Maine - one of our best fellows at @clevelandclinic.bsky.social and now as an oncologist in @Stanford medicine www.linkedin.com/posts/minhtr... @minhtrimd.bsky.social inspiring!

submitted 79 days ago • 1 comment

I was born in the mountains of 🇻🇳. At 5 my parents sought the land of opportunity 🇺🇸. This Dec our family reunited in 🇻🇳. My country has changed and so have we. Change = opportunity. From my Fam to yours: Happy new years! With the change, I hope you also find your opportunities to grow.

submitted 98 days ago • 0 comments

A bit late on the announcement but thrilled to be selected for the Stanford Physician Leadership Certificate Program! I look forward to learning and enhancing my leadership skills and leadership theory. I accept! (-ed before the deadline) :) #leadership

submitted 105 days ago • 1 comment

The selective estrogen-receptor degrader imlunestrant plus abemaciclib led to a median progression-free survival of 9.4 months among patients with ER-positive, HER2-negative breast cancer (vs. 5.5 months with imlunestrant alone). Full EMBER-3 trial results: nej.md/4fZ74HX #MedSky #SABCS24

submitted 116 days ago • 0 comments

I’ve found many apps to be extremely useful as a fellow and practicing oncologist. For a quick (usually less than 48 hrs) curbside consult to an Oncologist, Hematologist, RadOnc, Pharmacist etc. I’ve been using Primum. You can also ask anonymously. See link. #oncsky #cansky #medsky

submitted 115 days ago • 1 comment

We have known for decade+ that you can detect progression using ctDNA months before you see it on scans. But until we show that it impacts outcomes to change tx earlier all it does is make ppl anxious and abandon treatments (TKIs) that may still be helping. Most MRD use today is marketing over data.

submitted 119 days ago • 4 comments

Wrote this haiku before #ASHaiku for #ASH24 but I’d like to shamelessly repost for submission. In response to @oligoclonalband.bsky.social ‘s cooly made Neuro-skirt.

submitted 125 days ago • 2 comments

Day 2 of #BLADDR24 Dr Rob Jones Case metastatic UCa Treatment sequencing in the era of combination therapies Emphasizes that first-line therapy with EV and P is poised to become the new SoC @drnataliagandur.bsky.social @barbaramelao.bsky.social @yukselurun.bsky.social @achoud72.bsky.social

submitted 129 days ago • 0 comments

My interview on developing leaders in healthcare with James Stoller, MD and Scott Allen, Ph.D. #leadership #medsky

submitted 134 days ago • 0 comments

@valdesan.bsky.social to the rescue! Oncology Vol 1 and 2 starter packs (links included in the packs) go.bsky.app/UP8aWPd #medsky #oncsky #oncosky #oncology

submitted 134 days ago • 0 comments

Interesting case series (n=3) from Emory of patients with pretreated HER2+ and HER2-low MBC with severe hepatic impairment tolerating well and deriving clinical benefit from dose-reduced T-DXd. www.sciencedirect.com/science/arti...

submitted 135 days ago • 0 comments

Amazing. Imagine the next level: Incorporating such large language models into our EMR systems to provide suggested matched clinical trials in real time! These LLM are already being trialed and implemented for inbox management at some institutions. Anxiously hopeful. 🙏

submitted 139 days ago • 0 comments

Can we get one of those nifty “click to follow all of these profiles” for #oncosky #cansky? I’m thinking someone must being working on this…right? Or did I just volunteer myself? 😭 👉👃 #medsky

submitted 139 days ago • 4 comments

It’s getting a little hairy over there 👀…Time to find bluer skies. 🦋 #medsky #oncosky

submitted 140 days ago • 1 comment

Voting in the ASCO Election is open now until December 3! Meet the candidates for the Board of Directors – Undesignated Member seat. Learn more about each candidate, determine your voting eligibility, and make your voice heard at brnw.ch/21wOzu3

submitted 145 days ago • 0 comments